☰

Iana M. Serafimova, Ph.D. - Publications

Institution:
University of California, San Francisco, San Francisco, CA
Area:
signaling proteins
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Miller RM, Paavilainen VO, Krishnan S, Serafimova IM, Taunton J. Electrophilic fragment-based design of reversible covalent kinase inhibitors. Journal of the American Chemical Society. 135: 5298-301. PMID 23540679 DOI: 10.1021/Ja401221B  0.62
2013 Le NT, Heo KS, Takei Y, Lee H, Woo CH, Chang E, McClain C, Hurley C, Wang X, Li F, Xu H, Morrell C, Sullivan MA, Cohen MS, Serafimova IM, et al. A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis. Circulation. 127: 486-99. PMID 23243209 DOI: 10.1161/Circulationaha.112.116988  0.5
2012 Serafimova IM, Pufall MA, Krishnan S, Duda K, Cohen MS, Maglathlin RL, McFarland JM, Miller RM, Frödin M, Taunton J. Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles. Nature Chemical Biology. 8: 471-6. PMID 22466421 DOI: 10.1038/Nchembio.925  0.325
2009 Aragón T, van Anken E, Pincus D, Serafimova IM, Korennykh AV, Rubio CA, Walter P. Messenger RNA targeting to endoplasmic reticulum stress signalling sites. Nature. 457: 736-40. PMID 19079237 DOI: 10.1038/Nature07641  0.312
Show low-probability matches.